Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited)

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Operating expenses        
Research and development   $ 60,651 $ 25,000 $ 152,751
General and administrative $ 1,080,190 670,276 2,306,551 1,958,329
Total operating expenses 1,080,190 730,927 2,331,551 2,111,080
Operating loss (1,080,190) (730,927) (2,331,551) (2,111,080)
Interest expense     3,100  
Interest income (74)   (74)  
Other expense (income)        
Change in fair value of warrant liabilities 1,580,242 (26,437) 417,749 (38,998)
Fair value of warrant liability in excess of proceeds     7,174,634  
Change in fair value of conversion rights of Series B preferred stock   (3,326)   (88,532)
Change in fair value of conversion rights of convertible debt     185,000  
Financing transaction costs     137,191  
Loss on extinguishment of convertible debt     590,392  
Amortization of convertible debt discount     34,608  
Loss before income taxes (2,660,358) (701,164) (10,874,151) (1,983,550)
Provision for income taxes 1,642 1,600 1,642 2,431
Net loss and comprehensive loss (2,662,000) (702,764) (10,875,793) (1,985,981)
Less: Preferred deemed dividend       711,000
Net loss applicable to common shareholders $ (2,662,000) $ (702,764) $ (10,875,793) $ (2,696,981)
Basic earnings per common share (in dollars per share) $ (0.02) $ (0.02) $ (0.10) $ (0.10)
Diluted earnings per common share (in dollars per share) $ (0.02) $ (0.02) $ (0.10) $ (0.10)
Weighted average shares of common stock outstanding        
Basic (in shares) 130,668,887 28,376,141 109,767,054 25,814,315
Diluted (in shares) 130,668,887 28,376,141 109,767,054 25,814,315